We previously showed that multiple ApoER2-Dab1 pathway components accumulate together in five regions that degenerate in the earliest stages of AD,[25] and two regions that degenerate later in the disease process,[27] and proposed that ApoER2-Dab1 disruption could potentially be a universal mechanism underlying AD-related degeneration in humans. The gene discussed is DAB1; the disease is Alzheimer disease.